Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments. (2020)
Attributed to:
The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2020-215027
PubMed Identifier: 32943495
Publication URI: http://europepmc.org/abstract/MED/32943495
Type: Journal Article/Review
Volume: 75
Parent Publication: Thorax
Issue: 11
ISSN: 0040-6376